US Patent Issued to Paragon Therapeutics on May 20 for "Dosing regimen for treating inflammatory bowel disease" (Puerto Rico, New Hampshire, Massachusetts Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,956, issued on May 20, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.).

"Dosing regimen for treating inflammatory bowel disease" was invented by Peter Evan Harwin (Dorado, Puerto Rico), Tomas Kiselak (Dorado, Puerto Rico), Hussam Hisham Shaheen (Auburn, N.H.) and Eric Franklin Zhu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are variant Alpha4Beta7 integrin antibodies and methods of use."

The patent was filed on July 16, 2024, under Application No. 18/774,123.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&...